Mitochondria as potential targets in antidiabetic therapy

20Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A growing body of evidence suggests that mitochondrial abnormalities are involved in diabetes and associated complications. This chapter gives an overview about the effects of diabetes in mitochondrial function of several tissues including the pancreas, skeletal and cardiac muscle, liver, and brain. The realization that mitochondria are at the intersection of cells' life and death has made them a promising target for drug discovery and therapeutic interventions. Here, we also discuss literature that examined the potential protective effect of insulin, insulin-sensitizing drugs, and mitochondrial-targeted antioxidants. © 2011 Springer-Verlag.

Cite

CITATION STYLE

APA

Moreira, P. I., & Oliveira, C. R. (2011). Mitochondria as potential targets in antidiabetic therapy. Handbook of Experimental Pharmacology. Springer Science and Business Media, LLC. https://doi.org/10.1007/978-3-642-17214-4_14

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free